The latest update is out from CSPC Pharmaceutical Group ( (HK:1093) ).
CSPC Pharmaceutical Group Limited has announced that its board of directors will convene on March 28, 2025, to approve the company’s annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market position and investor relations.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company in the pharmaceutical industry, focusing on the development, production, and sale of pharmaceutical products. It operates with a market focus on providing healthcare solutions and medicines.
YTD Price Performance: 7.46%
Average Trading Volume: 4,371
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.16B
See more data about 1093 stock on TipRanks’ Stock Analysis page.